HIV and Other Retroviral Diseases Affecting Afro-Asian Continents

The global HIV/AIDS market, including branded products and generics, was esteemed at $11.3 billion in 2010. This market is expected to reach $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 estimate period to reach $14.1 billion in 2016.

The human immunodeficiency virus is a lentivirus that causes HIV infection and AIDS.HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies done to have a better approach, distinguish, or treat HIV/AIDS. Clinical trials are the fastest way to determine if new medical approaches to HIV/AIDS are safe and effective in people.

  • Systems biology in HIV, METH and cART
  • HIV diagnosis
  • HIV and retroviral transmission and prevention
  • Anti-retroviral therapies and associated complications
  • Psychological and social issues associated with HIV
  • Opportunistic diseases in HIV
  • Immunology of HIV and retroviral infections
  • Clinical trials in HIV AIDS
  • HIV vaccines and advances

Related Conference of HIV and Other Retroviral Diseases Affecting Afro-Asian Continents

March 18-19, 2024

53rd World Congress on Microbiology

Zurich, Switzerland
May 09-10, 2024

16th International Virology Summit

Barcelona, Spain
June 10-11, 2024

5th International Conference on Molecular Microbiology

Barcelona, Spain

HIV and Other Retroviral Diseases Affecting Afro-Asian Continents Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in